Dr. Deziree Angelita Durayappah , DO
General Practice β’ Houston, TX
11314 Valley Stream Dr
Houston, TX 770434624
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
Dr. Deziree Durayappah is listed in NPPES under General Practice.
-
NPI assigned on November 16, 2012; this date does not establish years in practice.
-
Published CMS data list 295 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers β by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Amlodipine Besylate β 26 prescription fills, including refills.
- Lisinopril β 24 prescription fills, including refills.
- Losartan Potassium β 24 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers β by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 18 records in the table Β· Guide: How to read Medicare Part D prescriber data
-
Fewer Part D prescriptions than 60% of clinicians listed under General Practice in Houston, TX (2024, 36 clinicians with data). Median for this group: 577. Middle half: 85 to 2,785.
Close to the middle for Part D prescriptions among clinicians listed under General Practice in Texas (2024, 221 clinicians with data). Median for this group: 452. Middle half: 78 to 2,858.
Source: CMS, Medicare Part D Prescribers β by Provider and Drug, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part D prescriptions went from 237 in 2023 to 295 in 2024.
Source: CMS, Medicare Part D Prescribers β by Provider and Drug, 2023β2024.
Practice Location & Contact Primary Location
11314 Valley Stream Dr
Houston, TX 770434624
What Public CMS Data Show
General Practice: NPPES taxonomy is a reported classification, not proof of board certification.
30-day fills
559 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$17,804 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers β by Provider and Drug, 2024.
Open Payments general payments, program year 2024
All general payments: $78.58 across 4 records.
By nature of payment
- Food and Beverage: $78.58 across 4 records.
Reporting-company totals
- AstraZeneca Pharmaceuticals LP: $40.04 across 2 records.
- Organon Llc: $21.65 across 1 record.
- Astellas Pharma US Inc: $16.89 across 1 record.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2024 (published June 30, 2026).
NPI first issued
2012
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Medicare assignment not listed
CMS data do not show whether this clinician accepts Medicare assignment. This does not mean they do not accept Medicare. Ask the office.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians; Medicare.gov, βDoes your provider accept Medicare as full payment?β
No telehealth indicator
CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians.
Can order Medicare-covered services
CMS lists Dr. Durayappah as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.
Medicare pays for these items and services only when they are ordered by an eligible clinician.
What this does not show: Can order Medicare-covered services
It does not mean the clinician offers these services directly.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Compared with the same specialty in Houston and Texas
Billing and prescribing volume is not a quality rating.
Medicare Part D prescriptions
Fewer Part D prescriptions than 60% of clinicians listed under General Practice in Houston, TX (2024, 36 clinicians with data). Median for this group: 577. Middle half: 85 to 2,785.
Close to the middle for clinicians listed under General Practice in Texas (2024, 221 clinicians with data). Median for this group: 452. Middle half: 78 to 2,858.
Part D drug cost
Close to the middle for clinicians listed under General Practice in Houston, TX (2024, 36 clinicians with data). Median for this group: $20,647. Middle half: $2,458 to $392,192.
Close to the middle for clinicians listed under General Practice in Texas (2024, 221 clinicians with data). Median for this group: $17,804. Middle half: $993 to $222,529.
133 active clinicians are listed under General Practice with a practice address in Houston, TX (1,066 in Texas).
Addresses are self-reported to NPPES and may be out of date.
Telehealth indicator in Houston
6.8% of these 133 clinicians have the CMS telehealth indicator.
30.1% of these 133 clinicians are listed by CMS as accepting Medicare assignment.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part D prescriptions
Medicare Part D prescriptions increased 24% from 237 in 2023 to 295 in 2024.
- 2023: 237
- 2024: 295
-
30-day fills
30-day fills increased 61% from 348 in 2023 to 559 in 2024.
- 2023: 348
- 2024: 559
-
Part D drug cost
Part D drug cost increased 502% from $2,957 in 2023 to $17,804 in 2024.
- 2023: $2,957
- 2024: $17,804
-
Industry payments (Open Payments)
Industry payments (Open Payments) went from $116.34 in 2019 to $78.58 in 2024.
- 2019: $116.34
- 2023: $34.48
- 2024: $78.58
Sources: CMS Medicare Part D Prescribers (2024), CMS Open Payments (2024), CMS Doctors and Clinicians, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo Β· Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2024 (payments made January 1 β December 31, 2024): fewer than 11 records totaling $78.58.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| Organon Llc |
Food and Beverage
In-kind items and services
|
NEXPLANON | General | $21.65 |
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
FARXIGA | General | $20.97 |
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
FARXIGA | General | $19.07 |
| Astellas Pharma US Inc |
Food and Beverage
In-kind items and services
|
Veozah | General | $16.89 |
Source: CMS Open Payments, program year 2024, released June 30, 2026.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Amlodipine Besylate | Amlodipine Besylate | 26 | 1,900 | $135.62 | 11 |
| Lisinopril | Lisinopril | 24 | 2,160 | $201.05 | β |
| Losartan Potassium | Losartan Potassium | 24 | 1,680 | $252.43 | β |
| Levothyroxine Sodium | Levothyroxine Sodium | 22 | 1,560 | $343.87 | β |
| Tramadol Hcl | Tramadol Hcl | 21 | 547 | $246.08 | β |
| Gabapentin | Gabapentin | 18 | 1,260 | $368.58 | β |
| Cefdinir | Cefdinir | 18 | 111 | $185.69 | 15 |
| Fluticasone Propionate | Fluticasone Propionate | 17 | 780 | $285.22 | β |
| Furosemide | Furosemide | 16 | 1,245 | $93.49 | β |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 14 | 120 | $91.94 | 11 |
| Azithromycin | Azithromycin | 13 | 65 | $54.94 | 13 |
| Alprazolam | Alprazolam | 13 | 380 | $34.12 | β |
| Prednisone | Prednisone | 12 | 53 | $24.42 | β |
| Metoprolol Succinate | Metoprolol Succinate | 12 | 1,004 | $324.74 | β |
| Farxiga | Dapagliflozin Propanediol | 12 | 780 | $14,460.11 | β |
| Metformin Hcl | Metformin Hcl | 11 | 810 | $67.71 | β |
| Tizanidine Hcl | Tizanidine Hcl | 11 | 435 | $93.90 | β |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 11 | 244 | $540.41 | β |
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
Self-certified to NPPES: 2026-07-29NUCC Taxonomy Code: 208D00000X
A physician who specializes in the general practice of diagnosing, treating, and managing patients with a variety of illnesses and conditions.
Medicare (PECOS) Enrollment & Ordering Eligibility
Source: CMS PECOSSources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.
Career & Practice History Timeline
Changes recorded in monthly NPPES data files: addresses, names, credentials, specialties and NPI status
Registered at 11314 VALLEY STREAM DR, HOUSTON, TX 770434624 (Tel: 3104303357)
Registered at 11314 VALLEY STREAM DR, HOUSTON, TX 770434624 (Tel: 3104303357)
Registered at 232288 E 640 RD, SEILING, OK 736636620 (Tel: 3104303357)
Registered at 232288 E 640 RD, SEILING, OK 736636620 (Tel: 3104303357)
General Practice (license number reported to NPPES: TX S4292)
Registered at 105 HOSPITAL AVE, TULIA, TX 790882433 (Tel: 8069954122)
Registered at PO BOX 846, TULIA, TX 790880846 (Tel: 8069954122)
Registered at 8762 LONG POINT RD STE 105, HOUSTON, TX 770553016 (Tel: 3104303357)
Registered at 11314 VALLEY STREAM DR, HOUSTON, TX 770434624 (Tel: 3104303357)
Recorded as DEZIREE DURAYAPPAH, D.O.
Family Medicine (license number reported to NPPES: TX S4292)
NPI status registered as active in NPPES database
Registered at 18109 HATTERAS ST, TARZANA, CA 913561709 (Tel: 3104303357)
Registered at 18109 HATTERAS ST, TARZANA, CA 913561709 (Tel: 3104303357)
Recorded as DEZIREE BARKER, D.O.
Student in an Organized Health Care Education/Training Program
First registered as active Individual Practitioner in NPPES Database.
NPI Administrative Meta
Other General Practices in Houston
- Dr. Stephen Vanroekel, DO
- Dr. Jeanne Southern, MD
- Dr. John Nemecek, MD
- Dr. Sudad Al Hadad, MD
- Dr. Manuel Garcia Galdo, MD
- Dr. Jesus Mayor, MD
Mailing Address
11314 Valley Stream Dr
Houston, TX 770434624
Phone: 3104303357